⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 1, 2015Journal of Gynecologic OncologyOpen Access

Distinguishing benign from malignant pelvic mass utilizing an algorithm with HE4, menopausal status, and ultrasound findings

Sarikapan Wilailak Karen K. Chan Chi‐An Chen Joo-Hyun Nam Kazunori Ochiai Tar Choon Aw Subathra Sabaratnam Sudarshan Hebbar Jaganathan Sickan Beth A. Schodin Chuenkamon Charakorn Walfrido W. Sumpaico

View Full Paper

Ask AI

Bookmark

Share

Abstract

Combining ultrasound with HE4 can improve the sensitivity for detecting ovarian cancer compared to other algorithms.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wilailak et al. (2015) studied this question.

synapsesocial.com/papers/69d8cfb133ca018b39ae419b https://doi.org/10.3802/jgo.2015.26.1.46

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Cancer Statistics, 2009Registry Study · 2009 · 9,712 citations
2Adherence to Treatment Guidelines for Ovarian Cancer as a Measure of Quality CareRegistry Study · 2013 · 221 citations
3A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancerOriginal Research · 1990 · 962 citations
4Prospective evaluation of the IOTA logistic regression model LR2 for the diagnosis of ovarian cancerCohort Study · 2012 · 57 citations
5The CA 125 tumour-associated antigen: a review of the literaturePrognostic Study · 1989 · 956 citations

More related papers

Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases2011
Evaluation of the Diagnostic Accuracy of the Risk of Ovarian Malignancy Algorithm in Women With a Pelvic Mass2011
Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case-control study in a Korean population2011

More from Journal of Gynecologic Oncology

Current status of fertility preservation for borderline ovarian tumor in Asian regions: results from ASGO-special task force for fertility preservation; part I. Fertility-sparing treatment for borderline ovarian tumorTue,
Effectiveness of first-line niraparib maintenance in Korean patients with advanced ovarian cancer: a multicenter retrospective cohort studyThu,